UN High-Level Meeting On Noncommunicable Diseases: A Call To Action 28/09/2018 David Branigan NEW YORK -- The United Nations General Assembly yesterday adopted a high-level political declaration on noncommunicable diseases like cancer or cardiovascular disease. And while it gives an infusion of political energy to the issue, some are concerned it did not go far enough and are urging strong actions to follow. Continue reading -> UN Negotiated Deal On Tuberculosis Declaration Stands 18/09/2018 David Branigan The negotiated deal over the language of the United Nations political declaration on tuberculosis, a landmark in the fight against TB, has been maintained by member states and finalised on 14 September, marking the end of intense negotiations over language on access to medicines in the document. Continue reading -> UN Tuberculosis Declaration Draft Text Out For Approval 11/09/2018 William New Negotiators' agreed draft text for a United Nations political declaration on ending tuberculosis worldwide has been posted for all member states to see, and negotiators hope, not comment on. Under a UN procedure, the text has been placed "under silence" until 10:00am New York time on 14 September. If no one breaks the silence, the text is considered agreed and will advance to the High-Level Meeting on tuberculosis on 26 September as part of the annual UN General Assembly. Continue reading -> Kenya Takes Steps To Tackle Non-Communicable Diseases 24/08/2018 Justus Wanzala Faced with the growing challenge of lifestyle diseases - already the second biggest killers in Kenya after HIV/AIDS, with cardiovascular diseases leading in the category - the government recently launched guidelines for cardiovascular disease management. Continue reading -> Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WIPO, IFPMA Speaker Says Despite Trump Actions, He Would Be US Science Envoy 24/08/2017 William New A United States State Department science envoy quit yesterday in protest over US President Donald Trump's pullout from the Paris climate accord and defensive comments after violence at a white nationalist rally in Charlottesville, Virginia. But according to a press report, Peter Hotez, a past science adviser who has been a featured speaker of a UN agency and pharmaceutical industry group in Geneva, is stepping up to offer his services without concern for Trump's actions. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> Posts navigation Newer posts
UN Negotiated Deal On Tuberculosis Declaration Stands 18/09/2018 David Branigan The negotiated deal over the language of the United Nations political declaration on tuberculosis, a landmark in the fight against TB, has been maintained by member states and finalised on 14 September, marking the end of intense negotiations over language on access to medicines in the document. Continue reading -> UN Tuberculosis Declaration Draft Text Out For Approval 11/09/2018 William New Negotiators' agreed draft text for a United Nations political declaration on ending tuberculosis worldwide has been posted for all member states to see, and negotiators hope, not comment on. Under a UN procedure, the text has been placed "under silence" until 10:00am New York time on 14 September. If no one breaks the silence, the text is considered agreed and will advance to the High-Level Meeting on tuberculosis on 26 September as part of the annual UN General Assembly. Continue reading -> Kenya Takes Steps To Tackle Non-Communicable Diseases 24/08/2018 Justus Wanzala Faced with the growing challenge of lifestyle diseases - already the second biggest killers in Kenya after HIV/AIDS, with cardiovascular diseases leading in the category - the government recently launched guidelines for cardiovascular disease management. Continue reading -> Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WIPO, IFPMA Speaker Says Despite Trump Actions, He Would Be US Science Envoy 24/08/2017 William New A United States State Department science envoy quit yesterday in protest over US President Donald Trump's pullout from the Paris climate accord and defensive comments after violence at a white nationalist rally in Charlottesville, Virginia. But according to a press report, Peter Hotez, a past science adviser who has been a featured speaker of a UN agency and pharmaceutical industry group in Geneva, is stepping up to offer his services without concern for Trump's actions. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> Posts navigation Newer posts
UN Tuberculosis Declaration Draft Text Out For Approval 11/09/2018 William New Negotiators' agreed draft text for a United Nations political declaration on ending tuberculosis worldwide has been posted for all member states to see, and negotiators hope, not comment on. Under a UN procedure, the text has been placed "under silence" until 10:00am New York time on 14 September. If no one breaks the silence, the text is considered agreed and will advance to the High-Level Meeting on tuberculosis on 26 September as part of the annual UN General Assembly. Continue reading -> Kenya Takes Steps To Tackle Non-Communicable Diseases 24/08/2018 Justus Wanzala Faced with the growing challenge of lifestyle diseases - already the second biggest killers in Kenya after HIV/AIDS, with cardiovascular diseases leading in the category - the government recently launched guidelines for cardiovascular disease management. Continue reading -> Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WIPO, IFPMA Speaker Says Despite Trump Actions, He Would Be US Science Envoy 24/08/2017 William New A United States State Department science envoy quit yesterday in protest over US President Donald Trump's pullout from the Paris climate accord and defensive comments after violence at a white nationalist rally in Charlottesville, Virginia. But according to a press report, Peter Hotez, a past science adviser who has been a featured speaker of a UN agency and pharmaceutical industry group in Geneva, is stepping up to offer his services without concern for Trump's actions. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> Posts navigation Newer posts
Kenya Takes Steps To Tackle Non-Communicable Diseases 24/08/2018 Justus Wanzala Faced with the growing challenge of lifestyle diseases - already the second biggest killers in Kenya after HIV/AIDS, with cardiovascular diseases leading in the category - the government recently launched guidelines for cardiovascular disease management. Continue reading -> Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WIPO, IFPMA Speaker Says Despite Trump Actions, He Would Be US Science Envoy 24/08/2017 William New A United States State Department science envoy quit yesterday in protest over US President Donald Trump's pullout from the Paris climate accord and defensive comments after violence at a white nationalist rally in Charlottesville, Virginia. But according to a press report, Peter Hotez, a past science adviser who has been a featured speaker of a UN agency and pharmaceutical industry group in Geneva, is stepping up to offer his services without concern for Trump's actions. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> Posts navigation Newer posts
Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WIPO, IFPMA Speaker Says Despite Trump Actions, He Would Be US Science Envoy 24/08/2017 William New A United States State Department science envoy quit yesterday in protest over US President Donald Trump's pullout from the Paris climate accord and defensive comments after violence at a white nationalist rally in Charlottesville, Virginia. But according to a press report, Peter Hotez, a past science adviser who has been a featured speaker of a UN agency and pharmaceutical industry group in Geneva, is stepping up to offer his services without concern for Trump's actions. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> Posts navigation Newer posts
WIPO, IFPMA Speaker Says Despite Trump Actions, He Would Be US Science Envoy 24/08/2017 William New A United States State Department science envoy quit yesterday in protest over US President Donald Trump's pullout from the Paris climate accord and defensive comments after violence at a white nationalist rally in Charlottesville, Virginia. But according to a press report, Peter Hotez, a past science adviser who has been a featured speaker of a UN agency and pharmaceutical industry group in Geneva, is stepping up to offer his services without concern for Trump's actions. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> Posts navigation Newer posts
The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> Posts navigation Newer posts